 | • レポートコード：D005-05195 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：化学・材料 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ジフテリア・百日咳・破傷風ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ジフテリア・百日咳・破傷風ワクチンの種類別市場規模（DTaP、Td、Tdap）、用途別市場規模（病院、クリニック、予防接種センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Johnson & Johnson、Emergent、Lanzhou Institute of Biological、GlaxoSmithKline、AstraZeneca、Sanofi、Novartis、Merck、Astellas ・地域別グローバル市場分析 2015年-2020年 ・ジフテリア・百日咳・破傷風ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・ジフテリア・百日咳・破傷風ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ジフテリア・百日咳・破傷風ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ジフテリア・百日咳・破傷風ワクチンの南米市場（ブラジル、アルゼンチン） ・ジフテリア・百日咳・破傷風ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：DTaP、Td、Tdap ・用途別分析：病院、クリニック、予防接種センター ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Diphtheria, Pertussis, and Tetanus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.7% in the forecast period of 2020 to 2025 and will expected to reach USD 2999.7 million by 2025, from USD 2595 million in 2019.
The Diphtheria, Pertussis, and Tetanus Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Diphtheria, Pertussis, and Tetanus Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Diphtheria, Pertussis, and Tetanus Vaccine market has been segmented into
DTaP
Td
Tdap
By Application, Diphtheria, Pertussis, and Tetanus Vaccine has been segmented into:
Hospitals
Clinics
Vaccination Centers
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Diphtheria, Pertussis, and Tetanus Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Diphtheria, Pertussis, and Tetanus Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Diphtheria, Pertussis, and Tetanus Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Diphtheria, Pertussis, and Tetanus Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Diphtheria, Pertussis, and Tetanus Vaccine Market Share Analysis
Diphtheria, Pertussis, and Tetanus Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Diphtheria, Pertussis, and Tetanus Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Diphtheria, Pertussis, and Tetanus Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Diphtheria, Pertussis, and Tetanus Vaccine are:
Johnson & Johnson
Emergent
Lanzhou Institute of Biological
GlaxoSmithKline
AstraZeneca
Sanofi
Novartis
Merck
Astellas
Among other players domestic and global, Diphtheria, Pertussis, and Tetanus Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Diphtheria, Pertussis, and Tetanus Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Diphtheria, Pertussis, and Tetanus Vaccine, with price, sales, revenue and global market share of Diphtheria, Pertussis, and Tetanus Vaccine in 2018 and 2019.
Chapter 3, the Diphtheria, Pertussis, and Tetanus Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Diphtheria, Pertussis, and Tetanus Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Diphtheria, Pertussis, and Tetanus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Diphtheria, Pertussis, and Tetanus Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Diphtheria, Pertussis, and Tetanus Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 DTaP
1.2.3 Td
1.2.4 Tdap
1.3 Market Analysis by Application
1.3.1 Overview: Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Vaccination Centers
1.4 Overview of Global Diphtheria, Pertussis, and Tetanus Vaccine Market
1.4.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Johnson & Johnson SWOT Analysis
2.1.4 Johnson & Johnson Product and Services
2.1.5 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Emergent
2.2.1 Emergent Details
2.2.2 Emergent Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Emergent SWOT Analysis
2.2.4 Emergent Product and Services
2.2.5 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Lanzhou Institute of Biological
2.3.1 Lanzhou Institute of Biological Details
2.3.2 Lanzhou Institute of Biological Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Lanzhou Institute of Biological SWOT Analysis
2.3.4 Lanzhou Institute of Biological Product and Services
2.3.5 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GlaxoSmithKline SWOT Analysis
2.4.4 GlaxoSmithKline Product and Services
2.4.5 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AstraZeneca SWOT Analysis
2.5.4 AstraZeneca Product and Services
2.5.5 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi SWOT Analysis
2.6.4 Sanofi Product and Services
2.6.5 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Novartis SWOT Analysis
2.7.4 Novartis Product and Services
2.7.5 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck SWOT Analysis
2.8.4 Merck Product and Services
2.8.5 Merck Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Astellas
2.9.1 Astellas Details
2.9.2 Astellas Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Astellas SWOT Analysis
2.9.4 Astellas Product and Services
2.9.5 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Diphtheria, Pertussis, and Tetanus Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Diphtheria, Pertussis, and Tetanus Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
6.4 France Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
7.5 India Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Diphtheria, Pertussis, and Tetanus Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Type (2015-2020)
11 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Segment by Application
11.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast (2021-2025)
12.2.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast (2021-2025)
12.2.4 South America Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast (2021-2025)
12.3 Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share Forecast by Type (2021-2025)
12.4 Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Diphtheria, Pertussis, and Tetanus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Major Business
Table 9. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. Johnson & Johnson SWOT Analysis
Table 11. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
Table 12. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Emergent Basic Information, Manufacturing Base and Competitors
Table 14. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Major Business
Table 15. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. Emergent SWOT Analysis
Table 17. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
Table 18. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Lanzhou Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 20. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Major Business
Table 21. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. Lanzhou Institute of Biological SWOT Analysis
Table 23. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
Table 24. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 26. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Major Business
Table 27. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Total Revenue (USD Million) (2017-2018)
Table 28. GlaxoSmithKline SWOT Analysis
Table 29. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
Table 30. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 32. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Major Business
Table 33. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Total Revenue (USD Million) (2017-2018)
Table 34. AstraZeneca SWOT Analysis
Table 35. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
Table 36. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Sanofi Basic Information, Manufacturing Base and Competitors
Table 38. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Major Business
Table 39. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Total Revenue (USD Million) (2017-2018)
Table 40. Sanofi SWOT Analysis
Table 41. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
Table 42. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Novartis Basic Information, Manufacturing Base and Competitors
Table 44. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Major Business
Table 45. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Total Revenue (USD Million) (2017-2018)
Table 46. Novartis SWOT Analysis
Table 47. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
Table 48. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Merck Basic Information, Manufacturing Base and Competitors
Table 50. Merck Diphtheria, Pertussis, and Tetanus Vaccine Major Business
Table 51. Merck Diphtheria, Pertussis, and Tetanus Vaccine Total Revenue (USD Million) (2017-2018)
Table 52. Merck SWOT Analysis
Table 53. Merck Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
Table 54. Merck Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Astellas Basic Information, Manufacturing Base and Competitors
Table 56. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Major Business
Table 57. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Total Revenue (USD Million) (2017-2018)
Table 58. Astellas SWOT Analysis
Table 59. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
Table 60. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Manufacturer (2018-2019) (K MT)
Table 62. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Regions (2015-2020) (K MT)
Table 64. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Regions (2015-2020)
Table 65. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Countries (2015-2020) (K MT)
Table 67. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Countries (2015-2020)
Table 68. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Countries (2015-2020)
Table 70. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Countries (2015-2020) (K MT)
Table 71. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Countries (2015-2020)
Table 72. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Regions (2015-2020) (K MT)
Table 74. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Countries (2015-2020) (K MT)
Table 77. South America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Countries (2015-2020)
Table 78. South America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Countries (2015-2020) (K MT)
Table 81. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Countries (2015-2020)
Table 84. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2015-2020) (K MT)
Table 85. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Type (2015-2020)
Table 86. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2015-2020) (USD Million)
Table 87. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Type (2015-2020)
Table 88. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2015-2020) (K MT)
Table 89. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Application (2015-2020)
Table 90. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Regions (2021-2025) (K MT)
Table 91. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share Forecast by Regions (2021-2025)
Table 92. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Type (2021-2025) (K MT)
Table 93. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share Forecast by Type (2021-2025)
Table 94. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Application (2021-2025)
Table 95. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Diphtheria, Pertussis, and Tetanus Vaccine Picture
Figure 2. Global Sales Market Share of Diphtheria, Pertussis, and Tetanus Vaccine by Type in 2019
Figure 3. DTaP Picture
Figure 4. Td Picture
Figure 5. Tdap Picture
Figure 6. Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application in 2018
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Vaccination Centers Picture
Figure 10. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Diphtheria, Pertussis, and Tetanus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Diphtheria, Pertussis, and Tetanus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Diphtheria, Pertussis, and Tetanus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Diphtheria, Pertussis, and Tetanus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Diphtheria, Pertussis, and Tetanus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Diphtheria, Pertussis, and Tetanus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Diphtheria, Pertussis, and Tetanus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Diphtheria, Pertussis, and Tetanus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Diphtheria, Pertussis, and Tetanus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Diphtheria, Pertussis, and Tetanus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Diphtheria, Pertussis, and Tetanus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Diphtheria, Pertussis, and Tetanus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Diphtheria, Pertussis, and Tetanus Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Diphtheria, Pertussis, and Tetanus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Diphtheria, Pertussis, and Tetanus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Diphtheria, Pertussis, and Tetanus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Diphtheria, Pertussis, and Tetanus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Manufacturer in 2019
Figure 31. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Diphtheria, Pertussis, and Tetanus Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Diphtheria, Pertussis, and Tetanus Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 36. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Regions (2015-2020)
Figure 38. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Regions in 2018
Figure 39. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
Figure 42. South America Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020)
Figure 44. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Countries (2015-2020)
Figure 46. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Countries in 2018
Figure 47. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Countries in 2018
Figure 49. United States Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Canada Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Mexico Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Countries in 2019
Figure 55. Germany Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 56. UK Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 57. France Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Russia Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Italy Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Regions 2019
Figure 63. China Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Japan Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Korea Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 66. India Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 68. South America Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Countries in 2019
Figure 70. South America Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Countries in 2019
Figure 71. Brazil Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Argentina Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Egypt Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Turkey Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 80. South Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2021-2025) (K MT)
Figure 82. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast (2021-2025) (K MT)
Figure 84. Europe Sales Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast (2021-2025) (K MT)
Figure 85. Asia-Pacific Sales Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast (2021-2025) (K MT)
Figure 86. South America Sales Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast (2021-2025) (K MT)
Figure 87. Middle East & Africa Sales Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast (2021-2025) (K MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
ジフテリア、破傷風、百日咳（DTaP）ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.…- 破傷風トキソイドワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tetanus Toxoid Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tetanus Toxoid Vaccine…
- ジフテリアトキソイドの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Diphtheria Toxoid market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Diphtheria Toxoid market re…
- 麻疹ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Measle Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Measle Vaccine market report p…
- ライム病ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Lyme Disease Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lyme Disease Vaccine mar…